Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 14 Feb 2018 |
2 | Journal Copy | 18 May 2018 |
3 | TM-O(NOTICE OF OPPOSITION) | 14 Jun 2018 |
4 | TM-O(NOTICE OF OPPOSITION) | 02 Aug 2018 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 27 Jan 2022 |
6 | Annexure -1 under rule 46 | 27 Jan 2022 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 09 Dec 2022 |
8 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 11 Apr 2024 |
1 | Opposition Notice | 7114342 | 3295132 | 09 Oct 2018 |
2 | Opposition Notice | 7135975 | 3316299 | 13 Oct 2018 |
3 | Opposition Counter Statement | 11175659 | 5132329 | 26 Feb 2021 |
4 | Opposition Counter Statement | 11175717 | 5132367 | 26 Feb 2021 |
5 | Hearing Notice | 17653903 | 6615704 | 07 Mar 2024 |
The application for Asunate was made on 14 February 2018.
The trademark applicant for Asunate is BLISS GVS PHARMA.
Asunate is applied in class(es) 5.
Application for Asunate is on Opposed stage.
Application Id allotted to Asunate is 3753139.
Trademark agent or attorney for the application is Innovative Consultants.
Asunate filed with the Intellectual property office as a DEVICE.